Who owns Protalix BioTherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PLX from SEC Form 13F filings across 104 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 104 institutions disclosed 14.7M shares of Protalix BioTherapeutics, Inc. worth $34.0M — about 18.3% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
104
13F holders
$34.0M
value, 2026 filers
18.3%
of shares outstanding (14.7M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PLX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.0M | $9.4M | 0.0% | 5.1% | +11.9% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 1.1M | $2.6M | 0.0% | 1.4% | -10.5% |
| 3 | STATE STREET CORP | 983,582 | $2.3M | 0.0% | 1.2% | +1.1% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 979,995 | $2.3M | 0.0% | 1.2% | +13.3% |
| 5 | NORTHERN TRUST CORP | 922,340 | $2.1M | 0.0% | 1.2% | +4.2% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 510,639 | $1.2M | 0.0% | 0.6% | +18.1% |
| 7 | Stratos Wealth Partners, LTD. | 500,000 | $1.2M | 0.0% | 0.6% | 0.0% |
| 8 | DIMENSIONAL FUND ADVISORS LP | 493,424 | $1.1M | 0.0% | 0.6% | +66.2% |
| 9 | GOLDMAN SACHS GROUP INC | 475,922 | $1.1M | 0.0% | 0.6% | +89.4% |
| 10 | MARSHALL WACE, LLPNEW | 452,757 | $1.1M | 0.0% | 0.6% | new |
| 11 | CITADEL ADVISORS LLCNEW | 334,227 | $778,749 | 0.0% | 0.4% | new |
| 12 | STRS OHIONEW | 296,100 | $689,913 | 0.0% | 0.4% | new |
| 13 | Bank of New York Mellon Corp | 232,992 | $542,871 | 0.0% | 0.3% | +6.2% |
| 14 | Main Street Financial Solutions, LLCNEW | 214,100 | $498,853 | 0.0% | 0.3% | new |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,100 | $440,603 | 0.0% | 0.2% | 0.0% |
| 16 | Hillsdale Investment Management Inc.NEW | 185,711 | $432,707 | 0.0% | 0.2% | new |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 180,381 | $420,288 | 0.0% | 0.2% | +13.2% |
| 18 | Sixth Street Partners Management Company, L.P.NEW | 180,381 | $420,288 | 0.1% | 0.2% | new |
| 19 | MILLENNIUM MANAGEMENT LLCNEW | 171,535 | $399,677 | 0.0% | 0.2% | new |
| 20 | AQR CAPITAL MANAGEMENT LLC | 167,826 | $391,035 | 0.0% | 0.2% | +450.4% |
| 21 | LAZARD ASSET MANAGEMENT LLC | 165,561 | $385,757 | 0.0% | 0.2% | +91.1% |
| 22 | UBS Group AG | 138,646 | $323,045 | 0.0% | 0.2% | -47.8% |
| 23 | JPMORGAN CHASE & CONEW | 132,991 | $312,529 | 0.0% | 0.2% | new |
| 24 | Nuveen, LLC | 90,188 | $210,138 | 0.0% | 0.1% | 0.0% |
| 25 | DEUTSCHE BANK AG\ | 77,537 | $180,661 | 0.0% | 0.1% | +3.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.